We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Alnylam Pharmaceuticals Inc | BOV:A1LN34 | Bovespa | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 36.84 | 36.10 | 41.29 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
0 | 20:54:52 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
26 Apr 2024 | 36.84 | 0.00 | 0.00% | 36.84 | 36.84 | 0 |
25 Apr 2024 | 36.84 | -0.96 | -2.54% | 36.84 | 36.84 | 1 |
24 Apr 2024 | 37.80 | 0.00 | 0.00% | 37.80 | 37.80 | 0 |
23 Apr 2024 | 37.80 | 0.00 | 0.00% | 37.80 | 37.80 | 0 |
22 Apr 2024 | 37.80 | -0.72 | -1.87% | 37.80 | 37.80 | 6 |
19 Apr 2024 | 38.52 | 0.00 | 0.00% | 38.52 | 38.52 | 0 |
18 Apr 2024 | 38.52 | 0.00 | 0.00% | 38.52 | 38.52 | 0 |
17 Apr 2024 | 38.52 | 0.00 | 0.00% | 38.52 | 38.52 | 0 |
16 Apr 2024 | 38.52 | 0.00 | 0.00% | 38.52 | 38.52 | 0 |
15 Apr 2024 | 38.52 | 0.00 | 0.00% | 38.52 | 38.52 | 1 |
12 Apr 2024 | 38.52 | -0.60 | -1.53% | 38.52 | 38.52 | 15 |
11 Apr 2024 | 39.12 | 0.00 | 0.00% | 39.12 | 39.12 | 0 |
10 Apr 2024 | 39.12 | -0.47 | -1.19% | 39.12 | 39.12 | 1 |
09 Apr 2024 | 39.59 | 0.00 | 0.00% | 39.59 | 39.59 | 0 |
08 Apr 2024 | 39.59 | 0.00 | 0.00% | 39.59 | 39.59 | 1 |
05 Apr 2024 | 39.59 | 3.36 | 9.27% | 39.59 | 39.59 | 2 |
04 Apr 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
03 Apr 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
02 Apr 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
01 Apr 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
28 Mar 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
27 Mar 2024 | 36.23 | 0.00 | 0.00% | 36.23 | 36.23 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions